Is α-Synuclein Rising to the Surface as a Diagnostic Biomarker for Parkinson’s Disease?

The long held hope that a remedy will be discovered to halt the progress of Parkinson disease (PD) will require the identification of early, accurate, and accessible biomarkers. Editors write that if neuronal pathology leading to PD was shown to involve peripheral nerves and be present in a more safely accessible tissue, the ability to detect diagnostically valid α-Synuclein pathology at the body’s surface would be a welcome advance.  READ MORE

Source: Neurology